コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 swabs (n=392) from symptomatic females with vaginal discharge.
2 y, presenting with anomalous bleeding and/or vaginal discharge.
5 group had a higher rate of increased or new vaginal discharge (86.7% vs 46.0%; between-group differe
6 ymptoms, the 2 most powerful were history of vaginal discharge and history of vaginal irritation, whi
8 l vaginosis (BV) is the most common cause of vaginal discharge and is associated with important publi
9 vestigated all women complaining of abnormal vaginal discharge and seeking care at maternal and child
10 ate models, vulvitis, genital ulcer disease, vaginal discharge, and Candida vaginitis were significan
11 laboratory tests, particularly microscopy of vaginal discharge, are the most useful way of diagnosing
13 ed search terms of diagnosis with vaginitis, vaginal discharge, candidiasis, bacterial vaginosis, and
14 infection but were elevated in women who had vaginal discharge, detectable HIV-1 RNA in their genital
15 he most recent sexual partner; and (c) itchy vaginal discharge in the previous 30 d, possibly indicat
16 pain (LR, 0.8; 95% CI, 0.7-0.9), history of vaginal discharge (LR, 0.3; 95% CI, 0.1-0.9), history of
17 l irritation (LR, 0.2; 95% CI, 0.1-0.9), and vaginal discharge on examination (LR, 0.7; 95% CI, 0.5-0
18 symptoms (eg, dysuria and frequency without vaginal discharge or irritation) raise the probability o
20 articularly gynecological complaints such as vaginal discharge (OR, 3.2; 95% CI, 2.2-4.8) and dyspare
21 of a symptomatic partner, dysuria, abnormal vaginal discharge, or a new sex partner during the prece
22 y, patients on tamoxifen alone reported more vaginal discharge over the 5 years than patients on tamo
26 s associated with fewer hot flashes and less vaginal discharge than tamoxifen, but with more vaginal
27 present with additional symptoms, including vaginal discharge, vaginal pain/pressure, suprapubic pai
33 ds of condom use and increased odds of itchy vaginal discharge, which is potentially indicative of se
34 e seen for any endocrine symptoms apart from vaginal discharge, which was more pronounced with tamoxi
35 reported significantly fewer cold sweats and vaginal discharge, yet more vaginal dryness, painful int
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。